Evolus Inc (EOLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1111)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EOLS's Discussions on Twitter

Compare EOLS vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EOLS Evolus Inc	4.30	277.43M	202.09M	-61.69M	-35.64M	-1.08
TAK Takeda Pharmaceutical Co Adr	18.46	58.03B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	126.65	55.37B	9.40B	2.65B	2.24B	5.935
HLN Haleon Plc Adr	11.20	49.70B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	33.98	39.50B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	473.66	20.50B	3.13B	1.27B	1.12B	26.39

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-06	Herabstufung	Needham	Buy → Hold
2025-04-17	Eingeleitet	BTIG Research	Buy
2024-01-29	Hochstufung	Barclays	Equal Weight → Overweight
2022-06-23	Eingeleitet	Needham	Buy
2022-05-12	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-20	Hochstufung	Truist	Hold → Buy
2021-05-06	Hochstufung	Mizuho	Neutral → Buy
2021-04-08	Bestätigt	H.C. Wainwright	Buy
2021-02-24	Herabstufung	Truist	Buy → Hold
2020-07-07	Herabstufung	Mizuho	Buy → Neutral
2020-02-06	Fortgesetzt	Mizuho	Buy
2019-11-26	Eingeleitet	SVB Leerink	Outperform
2019-09-05	Fortgesetzt	Mizuho	Buy
2019-06-28	Eingeleitet	Wells Fargo	Market Perform
2019-06-11	Eingeleitet	Barclays	Underweight
2019-03-20	Eingeleitet	SunTrust	Buy
2019-02-14	Eingeleitet	H.C. Wainwright	Buy
2019-01-29	Eingeleitet	Stifel	Buy

Alle ansehen

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Finanzdaten der Evolus Inc-Aktie (EOLS)

Evolus Inc-Aktie (EOLS) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Avelar Rui	See Remarks	Dec 22 '25	Sale	7.15	2,261	16,168	356,821
Yamagishi-Dressler Tomoko	Chief Marketing Officer	Aug 22 '25	Sale	7.51	5,722	42,972	89,949
Stewart Brady	Director	Aug 15 '25	Buy	6.82	30,000	204,486	88,629
MOATAZEDI DAVID	See Remarks	Jun 13 '25	Sale	10.05	111,323	1,119,141	381,509
MOATAZEDI DAVID	See Remarks	Jun 16 '25	Sale	9.89	16,582	164,054	364,927

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

Compare EOLS vs TAK, ZTS, HLN, TEVA, UTHR

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

How Evolus Inc. stock compares to growth peers2025 Volume Leaders & High Yield Equity Trading Tips - mfd.ru

Is Evolus Inc. undervalued by DCF analysis2025 Trade Ideas & High Conviction Buy Zone Picks - mfd.ru

What Catalysts Are Rewriting The Evolus (EOLS) Story After The Guidance Reset - Yahoo Finance

Mizuho Lowers Price Target on Evolus, Inc. (EOLS) to $15, Maintains Outperform Rating - Insider Monkey

CEO Change: Is Evolus Inc undervalued by DCF analysis2025 Trade Ideas & AI Driven Price Forecasts - baoquankhu1.vn

Aug Patterns: Is Evolus Inc showing insider buyingMarket Trend Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Evolus, Inc. (NASDAQ:EOLS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

What is HC Wainwright's Forecast for Evolus FY2026 Earnings? - MarketBeat

HC Wainwright Forecasts Evolus' Q4 Earnings (NASDAQ:EOLS) - MarketBeat

Mizuho lowers Evolus stock price target to $15 on guidance reset - Investing.com Canada

Aug Opening: What hedge funds are buying Evolus IncWatch List & AI Optimized Trade Strategies - baoquankhu1.vn

Volatility Watch: What is the earnings history of Evolus IncPortfolio Update Report & Safe Entry Zone Tips - baoquankhu1.vn

H.C. Wainwright lowers Evolus stock price target to $13 on aesthetics headwinds - Investing.com Canada

HC Wainwright Lowers Evolus (NASDAQ:EOLS) Price Target to $13.00 - MarketBeat

Evolus, Inc. (EOLS) Stock Analysis: Unveiling A Compelling 264.81% Upside Potential - DirectorsTalk Interviews

Botulinum Toxin Market to Grow Strongly Through 2030 | Aesthetic - openPR.com

How A New Price Target Is Shaping The Evolus (EOLS) Story - Yahoo Finance

Evolus (NASDAQ:EOLS) Given New $13.00 Price Target at BTIG Research - MarketBeat

EOLS: BTIG Lowers Price Target While Maintaining Buy Rating | EO - GuruFocus

Understanding Momentum Shifts in (EOLS) - Stock Traders Daily

BTIG lowers Evolus stock price target to $13 on aesthetic market decline - Investing.com Nigeria

Evolus projects robust 2025 growth with upcoming product launches - MSN

Panic Selling: Should you avoid Evolus Inc stock right nowEarnings Performance Report & Capital Efficient Trade Techniques - baoquankhu1.vn

Lacklustre Performance Is Driving Evolus, Inc.'s (NASDAQ:EOLS) 30% Price Drop - 富途牛牛

VIX Spike: Is Evolus Inc undervalued by DCF analysis2025 Market WrapUp & Safe Entry Trade Reports - baoquankhu1.vn

Stifel Analyst Lowers Price Target on Evolus (EOLS) to $17.00 | - GuruFocus

Stifel lowers Evolus stock price target to $17 on tempered growth outlook - Investing.com Australia

Stifel lowers Evolus stock price target to $17 on tempered growth outlook By Investing.com - Investing.com South Africa

Evolus, Inc. (NASDAQ:EOLS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Avoiding Lag: Real-Time Signals in (EOLS) Movement - Stock Traders Daily

Evolus reports 15% Q4 growth, projects 2026 profitability By Investing.com - Investing.com Nigeria

Evolus sees FY26 revenue $327M-$337M, consensus $351.66M - TipRanks

Evolus sees Q4 revenue $88.6M-$90.6M, consensus $90.91M - TipRanks

Evolus, Inc. (EOLS) Stock Analysis: Unpacking a 222% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews

EOLS: HC Wainwright & Co. Reiterates Buy Rating with $20 Price T - GuruFocus

Evolus' (EOLS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Evolus (EOLS) Projects Strong Revenue Growth Through 2028 - GuruFocus

EOLS Projects Strong Revenue Growth with Key Product Line - GuruFocus

Evolus (EOLS) Achieves Sixth Year of Double-Digit Growth in 2025 - GuruFocus

EOLS Projects Optimistic Growth with Strategic Market Expansion - GuruFocus

Evolus outlook FY sales USD 327-337 million - marketscreener.com

Evolus reports 15% Q4 growth, projects 2026 profitability - Investing.com

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Business Wire

How Evolus Inc. stock valuations compare to rivalsMarket Growth Review & Stock Timing and Entry Methods - Улправда

Does Evolus Inc. stock trade at a discount to peersChart Signals & Reliable Breakout Forecasts - Улправда

Why Evolus Inc. stock is favored by top institutions2025 Performance Recap & Expert Curated Trade Setup Alerts - Улправда

Finanzdaten der Evolus Inc-Aktie (EOLS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Evolus Inc-Aktie (EOLS) Insiderhandel

Ähnlich wie EOLS